Related Experiment Video

Updated: May 25, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Meeting the challenges of an emerging pathogen: the Henry Schueler 41&9 Foundation International Forum on

Thomas J Walsh1, Bruce E Bloom, Dimitrios P Kontoyiannis

  • 1Transplantation-Oncology Infectious Diseases Program, Weill Cornell University Medical Center, 1300 York Avenue, New York, NY 10065, USA. thw2003@medcornelledu

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|January 17, 2012
PubMed

Insights

Invasive mucormycosis is a severe fungal infection affecting immunocompromised individuals. Advances in understanding and managing this infection are crucial for improving patient outcomes.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunocompromised Host

Background:

  • Invasive mucormycosis presents as a life-threatening infection with high morbidity and mortality.
  • Affects vulnerable pediatric and adult immunocompromised patients through pulmonary, sinal, rhinocerebral, and disseminated routes.
  • Emerging fungal infections pose significant global health challenges.

Discussion:

  • Current understanding of epidemiology, taxonomy, pathogenesis, pharmacology, host defenses, and microbiology is advancing.
  • Critical needs remain for enhanced diagnostic, therapeutic, and preventive strategies.
  • This supplement honors Hank Schueler's fight against invasive mucormycosis.

Key Insights:

  • Comprehensive resource for current management approaches to invasive mucormycosis.
  • Reviews key advances in combating this severe fungal infection.
  • Highlights the importance of interdisciplinary research in mycology and infectious diseases.

Outlook:

  • Continued research is vital for improving diagnosis, treatment, and prevention of mucormycosis.
  • Focus on vulnerable populations requires tailored strategies.
  • Translating research into clinical practice is essential for reducing mortality.

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...